Identification | More | [Name]
2-Thiopheneethanol | [CAS]
5402-55-1 | [Synonyms]
2-(2-HYDROXYETHYL)THIOPHENE 2-(2-THIENYL)ETHANOL 2-THIENYLETHANOL 2-THIOPHENEETHANOL 2-THIOPHENETHANOL THIOPHENE-2-ETHANOL Ethanol, 2-(2-thienyl)- Thiopheneethanol B-(B-THIENYL)ETHANOL THIOPHENE-2-ETHYANOL 2-THIOPHEN-2-YLETHANOL 2-(2-THIENYL) ETHANOL (THIOPHENE-2-ETHANOL) 2-(2-Hydroxyethyl)thiophene, 2-(2-Thienyl)ethanol 2-(2-Thienyl)ethyl alcohol | [EINECS(EC#)]
226-452-0 | [Molecular Formula]
C6H8OS | [MDL Number]
MFCD00005462 | [Molecular Weight]
128.19 | [MOL File]
5402-55-1.mol |
Chemical Properties | Back Directory | [Appearance]
clear light yellow to grey-green or brownish | [Boiling point ]
108-109 °C/13 mmHg (lit.) | [density ]
1.153 g/mL at 25 °C(lit.)
| [refractive index ]
n20/D 1.551(lit.)
| [Fp ]
214 °F
| [storage temp. ]
Store below +30°C. | [solubility ]
Chloroform (Slightly), Ethyl Acetate (Slightly) | [form ]
Liquid | [pka]
14.77±0.10(Predicted) | [color ]
Clear light yellow to gray-green or brownish | [Water Solubility ]
slightly soluble | [Detection Methods]
GC | [BRN ]
106985 | [LogP]
1.040 (est) | [CAS DataBase Reference]
5402-55-1(CAS DataBase Reference) | [NIST Chemistry Reference]
2-Thiopheneethanol(5402-55-1) | [EPA Substance Registry System]
5402-55-1(EPA Substance) |
Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S23:Do not breathe gas/fumes/vapor/spray (appropriate wording to be specified by the manufacturer) . S24/25:Avoid contact with skin and eyes . S36:Wear suitable protective clothing . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . | [RIDADR ]
UN 3334 | [WGK Germany ]
3
| [F ]
13 | [Hazard Note ]
Irritant | [TSCA ]
Yes | [HS Code ]
29349990 |
Hazard Information | Back Directory | [Chemical Properties]
clear colorless to slightly brown liquid | [Uses]
2-Thiopheneethanol is a thiophene derivative used in the preparation of oligothiophene isothiocyanates as fluorescent markers for biopolymers. 2-Thiopheneethanol is also used in the preparation of oth
er biologically active compounds such as the analgesic Sulfentanyl and the antithrombotic Clopidogrel Hydrogen Sulfate (C587250). | [Definition]
ChEBI: 2-(2-Thienyl)ethanol is a heteroarene. | [Synthesis Reference(s)]
Journal of the American Chemical Society, 64, p. 477, 1942 DOI: 10.1021/ja01255a001 The Journal of Organic Chemistry, 59, p. 4323, 1994 DOI: 10.1021/jo00094a056 | [Synthesis]
2.3. Biotransformation experiments: liquid culture inoculum was prepared by pre-culturing the fungal strains in Petri dishes containing malt extract solid medium (MEA: glucose 20 g/L, malt extract 20 g/L, agar 20 g/L, peptone 2 g/L). The fungus was inoculated as a conidial suspension (1 × 10^6 conidia/mL) in a 50 mL conical flask containing 40 mL of malt extract liquid medium. The conical flasks were placed in a constant temperature shaker at 25°C and incubated with oscillation at 110 rpm. After 2 days of preincubation, a DMSO solution with 500 mM substrate was added to give a starting substrate concentration (c0) of 1-5 mM. Three biological replicates were set up for each substrate. After addition of substrate, the experiment continued for 3 days, during which time 1 mL was sampled at predetermined time intervals (typically 24, 48, and 72 h.) After each sampling, the sample was extracted with 500 μL of ethyl acetate (EtOAc), and the organic phase was dried over anhydrous Na2SO4 and analyzed by GC/MS. In some cases (see Section 2.4), the reduction products were separated. Before each set of biotransformation experiments, initial biomass and pH were determined. At the end of the experiment, these parameters were evaluated again. The liquid medium was separated from the biomass by filtration for pH measurements; mycelium was dried at 60°C for 24 h and the dry weight of the biomass was determined. The yield of the product 2-(thiophen-2-yl)ethanol was 72% (3.7 mg) and the yield of the by-product methyl 2-(thiophen-2-yl)acetate was 96% (24.6 mg).1H NMR (400 MHz, CDCl3, TMS): δ = 7.20 (m, 1H, heteroaromatic hydrogens), 6.99 (m, 1H, heteroarylhydrogen), 6.90 (m, 1H, heteroaromatic hydrogen), 3.85 (t, 2H, J=6.2 Hz, CH2OH), 3.02 (t, 2H, J=6.2 Hz, CH2CH2OH). 13C NMR (100 MHz, CDCl3, TMS): δ=140.5, 127.0, 125.8, 124.0, 63.4, 33.3. GC/MS: tR= 9.47 min, m/z 128 (M+, 30%), 110 (5%), 97 (100%). | [References]
[1] Journal of Medicinal Chemistry, 1998, vol. 41, # 3, p. 346 - 357 [2] Chemical Communications (Cambridge, United Kingdom), 2012, vol. 48, # 85, p. 10514 - 10516,3 [3] European Journal of Organic Chemistry, 2011, # 17, p. 3178 - 3183 [4] Journal of Molecular Catalysis B: Enzymatic, 2015, vol. 116, p. 83 - 88 [5] Patent: US2010/16365, 2010, A1. Location in patent: Page/Page column 26 |
|
|